Antitumor Activity and Safety of the Pan-TRK, ROS1, and ALK inhibitor Entrectinib (RXDX-101): Combined Results from Two Phase I Trials
Drilon, A.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
High affinity nerve growth factor receptor | 293 | Homo sapiens | Mutation(s): 0  Gene Names: NTRK1, MTC, TRK, TRKA EC: 2.7.10.1 | ![]() | |
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for P04629 (Homo sapiens) Explore P04629  Go to UniProtKB:  P04629 | |||||
PHAROS:  P04629 GTEx:  ENSG00000198400  | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P04629 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 2 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
YMX Query on YMX | B [auth A] | Entrectinib C31 H34 F2 N6 O2 HAYYBYPASCDWEQ-UHFFFAOYSA-N | |||
GOL Query on GOL | C [auth A] | GLYCEROL C3 H8 O3 PEDCQBHIVMGVHV-UHFFFAOYSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 75.9 | α = 90 |
b = 75.9 | β = 90 |
c = 111.74 | γ = 120 |
Software Name | Purpose |
---|---|
REFMAC | refinement |
iMOSFLM | data reduction |
SCALA | data scaling |
BALBES | phasing |